Exp Mol Med.  2008 Aug;40(4):370-376. 10.3858/emm.2008.40.4.370.

Structure-antimicrobial activity relationship between pleurocidin and its enantiomer

Affiliations
  • 1School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Korea. dglee222@knu.ac.kr

Abstract

To develop novel antibiotic peptides useful as therapeutic drugs, the enantiomeric analogue of pleurocidin (Ple), which is a well known 25-mer antimicrobial peptide, was designed for proteolytic resistance by D-amino acids substitution. The proteolytic resistance was confirmed by using HPLC after the digestion with various proteases. To investigate the antibiotic effect of L- and D-Ple, the antibacterial activity and hemolytic effect were tested against human erythrocytes. The D-Ple showed a decreased antibacterial activity and a dramatically decreased hemolytic activity compared with L-Ple. The hemolytic effect of analogue was further confirmed by using calcein leakage measurement with liposome. To elucidate these results, the secondary structure of the peptides was investigated by using circular dichroism spectroscopy. The results revealed that D-Ple, as well as L-Ple, had typical ?-helical structures which were mirror images, with a different helicity. These results suggested that the discrepancy of the structure between the two peptides made their antibacterial activity distinct.

Keyword

anti-bacterial agents; hemolysis; molecular structure; pleurocidin; structure-activity relationship

MeSH Terms

Anti-Infective Agents/*chemistry/*pharmacology
Erythrocytes/drug effects
Fish Proteins/*chemistry/*pharmacology
Gram-Negative Bacteria/drug effects
Gram-Positive Bacteria/drug effects
Hemolytic Agents/chemistry/pharmacology
Humans
Microbial Sensitivity Tests
Stereoisomerism
Structure-Activity Relationship
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr